Drug Testing Locations - Grand Mesa, CO

Drug Testing in Grand Mesa, CO

Grand Mesa, Colorado Statistics

In Grand Mesa, CO, located within Mesa County, an estimated 8.5% of residents reported using illicit drugs in the past month in a recent survey.

Mesa County, including Grand Mesa, saw a 12% increase in drug-related arrests between 2021 and 2022.

The opioid overdose death rate in Mesa County, which includes Grand Mesa, was 20 per 100,000 residents in 2022.

A survey found that 16% of high school students in Grand Mesa, CO, part of Mesa County, admitted to using marijuana in the past month.

In 2022, Mesa County reported a 15% rise in emergency room visits related to drug overdoses, impacting areas like Grand Mesa.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Grand Mesa, CO & Drug Testing Policies

Employers in Grand Mesa, CO, and Drug Testing Policies

Businesses in Grand Mesa, within Mesa County, often adopt strict drug testing policies to ensure a drug-free workplace. Many utilize random testing and pre-employment screenings to adhere to state regulations and promote a healthy work environment.

Employers collaborate with agencies like the Colorado Department of Labor and Employment to align their workplace policies with best practices and state laws regarding drug screening and workplace safety. These policies often serve as a deterrent to drug use among employees.

Government Efforts with Drug Problems in Grand Mesa, CO

Government Efforts to Address Drug Problems in Grand Mesa, CO

The local government in Grand Mesa, CO, has partnered with the Mesa County Public Health department to implement programs aimed at reducing drug abuse. Initiatives like community education and support services are at the forefront.

State efforts involve collaboration with the Colorado Department of Human Services to provide treatment and prevention programs targeting substance abuse in regions including Grand Mesa. Increased funding is being directed toward facilities offering comprehensive addiction treatment services.

Local Drug Busts & News in Grand Mesa, CO

Local Drug Busts or Drug Related Events in Grand Mesa, CO

In recent years, Grand Mesa law enforcement agencies have conducted several successful drug busts, seizing significant quantities of illegal substances. These operations, often carried out with the assistance of the DEA, aim to curb drug trafficking in the region.

The community has also seen events like drug take-back days organized by local authorities, which encourage residents to dispose of unused medications safely, thereby reducing the risk of misuse and environmental harm.

Widespread drug awareness campaigns and public forums in Grand Mesa are regularly held to educate residents about the dangers of drug abuse and to promote resources for those needing help.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Grand Mesa, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Colorado Department of Public Health & Environment

New Directions for Women

Mesa County Drug Free Coalition

SAMHSA National Helpline

NAMI - National Alliance on Mental Illness

The Recovery Village

Colorado Prescription Drug Monitoring Program

My Life Recovery Centers

Drug Testing Near Grand Mesa, CO

Whitewater, CO

Clifton, CO

Bowie, CO

De Beque, CO

Paonia, CO

Hotchkiss, CO

Palisade, CO

Whitewater-Kahnah Creek, CO

Lazear, CO

Orchard City, CO

Collbran, CO

Delta, CO

Molina, CO

Cedaredge, CO

Twin Lakes, CO

Frequently Asked Questions

Customer Reviews